[O2–17–03]: A PHASE I STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF RO7105705 IN HEALTHY VOLUNTEERS AND PATIENTS WITH MILD‐TO‐MODERATE AD. (1st July 2017) - Kerchner, Geoffrey A.; Ayalon, Gai; Brunstein, Flavia; Chandra, Priya; Datwani, Akash; Fuji, Reina N.; Manser, Paul T.; Vaze, Anjali; Ward, Michael; Wildsmith, Kristin R.; Foo‐Atkins, Corinne